Dr Khoo Chong Yee will be speaking on “Patentability of Biotechnological Inventions” at the LexisNexis “Intellectual Property for Biotech: Understanding IP Valuation and Exploitation” conference.

Topics covered include:

  • What is patentable biotech subject matter?
  • Patentability requirements
  • Gathering and interpreting patent data
  • Understanding the technical and ethical aspects of biotechnological inventions
  • The effects on biotechnology research and development
  • Duration and renewal of patents
  • Examining alternatives to patent protection
  • The conference will be held on Monday, 16 June 2008, 9.00am – 5.30pm at the Berjaya Times Square, Kuala Lumpur.

From the LexisNexis website:

“Intellectual Property For Biotech: Understanding IP Valuation and Exploitation. 16 June 2008, 9:00 am - 5:30 pm Berjaya Times Square Hotel, Kuala Lumpur

The recent survey (2007) by the World Intellectual Property Organisation (WIPO) measured the economic impact of IP systems in six Asian countries; China, India, Japan, Malaysia, the Republic of Korea and Vietnam. The report examines the impact of the IP system on areas such as R&D, foreign direct investments (FDI) and technology transfer. It finds “a positive correlation between the strengthening of the IP system and subsequent economic growth”.

LexisNexis is proud to present this comprehensive one-day conference focusing on a range of different intellectual property right protection and examines important issues such as intellectual property exploitation and also a comprehensive overview of intellectual property valuation. Hear from leading partners from Drew & Napier LLC, Kandiah & Associates, Tay & Partners and Cantab IP.

Gain exclusive knowledge on biotech IP protection, technology transfer and strategic management of IP rights. Discover all the key factors to be taken into account when exploring IP for biotech inventions and innovations.”

Please visit the LexisNexis website or email Tevandran Manickam for more information.

← Back to News